Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial to Evaluate the Safety and Effectiveness of "OLIZ," a Combined Wavelength Photobiomodulation Medical Device, for Surgical Site Pain Relief in Patients Who Have Undergone Total Knee Arthroplasty (TKA) : A Multicenter, Controlled, and Randomized Clinical Trial

NCT07091773 is registered in ClinicalTrials.gov with LTBIO Co., Ltd. as lead sponsor.

NCT NCT07091773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07091773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial to Evaluate the Safety and Effectiveness of "OLIZ," a Combined Wavelength Photobiomodulation Medical Device, for Surgical Site Pain Relief in Patients Who Have Undergone Total Knee Arthroplasty (TKA) : A Multicenter, Controlled, and Randomized Clinical Trial
Lead sponsor
LTBIO Co., Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 20, 2025
Completion date
June 30, 2026
Enrollment
68 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative pain management during rehabilitation in patients undergoing total knee arthroplasty